Inhibikase Therapeutics shares owned by Vanguard Global Advisers
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Vanguard Global Advisers
from 13F filings
Historical chart of Vanguard Global Advisers investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Vanguard Global Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $61k | 37k | 1.68 |